- Home
- NSRX vs PIII Comparison
NSRX vs PIII Comparison
Compare NSRX & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSRX | PIII |
|---|---|---|
| Founded | 2019 | 2015 |
| Country | Israel | United States |
| Employees | 7 | 320 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.9M | 37.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NSRX | PIII |
|---|---|---|
| Price | $3.07 | $10.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $19.67 | $9.00 |
| AVG Volume (30 Days) | 41.8K | ★ 239.4K |
| Earning Date | 03-25-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.67 |
| Revenue Next Year | N/A | $2.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.98 | $1.52 |
| 52 Week High | $9.99 | $16.89 |
Technical Indicators
Market Signals| Indicator | NSRX | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 50.63 | 50.61 |
| Support Level | $2.78 | $9.80 |
| Resistance Level | $3.58 | $11.30 |
| Average True Range (ATR) | 0.27 | 1.51 |
| MACD | -0.00 | -0.54 |
| Stochastic Oscillator | 32.17 | 21.54 |
Price Performance
Historical ComparisonAbout NSRX Nasus Pharma Ltd. Ordinary Shares
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.